FIRST-LINE DASATINIB PLUS CONVENTIONAL CHEMOTHERAPY IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: THE KOREAN PROSPECTIVE PHASE II STUDY

被引：0

作者：

Lee, S. ^{[1
]}

Kim, D. W. ^{[1
]}

Kim, Y. J. ^{[1
]}

Yhim, H. Y. ^{[2
]}

Kwak, J. Y. ^{[2
]}

Yang, D. H. ^{[3
]}

Lee, J. J. ^{[3
]}

Kim, S. J. ^{[4
]}

Kim, J. S. ^{[4
]}

Park, S. J. ^{[5
]}

Choi, C. W. ^{[5
]}

Eom, H. S. ^{[6
]}

Park, S. K. ^{[7
]}

Lee, J. W. ^{[1
]}

Min, W. S. ^{[1
]}

Park, C. W. ^{[1
]}

机构：

[1] Catholic Univ Korea, Catholic BMT Ctr, Seoul, South Korea

[2] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea

[3] Chonnam Natl Univ, Hwasun Hosp, Hwasun Gun, Jeollanamdo, South Korea

[4] Yonsei Univ, Coll Med, Seoul, South Korea

[5] Korea Univ, Coll Med, Seoul, South Korea

[6] Natl Canc Ctr, Ilsan, South Korea

[7] Soonchunhyang Univ, Sch Med, Bucheon, South Korea

来源：

HAEMATOLOGICA | 2012年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1123

引用

页码：462 / 463

页数：2

共 50 条

[31] SEVERE HEMORRHAGIC COLITIS CAUSED BY DASATINIB IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Shimokaze, Tomoyuki
Mitsui, Tetsuo
Takeda, Hiroaki
Kawakami, Takako
Arai, Takahiko
Ito, Masafumi
Iwaba, Akiko
Izumino, Hiroko
Takahashi, Noriyuki
Kanno, Miyako
Sendo, Dai
Hayasaka, Kiyoshi
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (06) : 448 - 453
[32] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
Couturier, Marie-Anne
Thomas, Xavier
Raffoux, Emmanuel
Huguet, Francoise
Berthon, Celine
Simand, Celestine
Gallego-Hernanz, Maria-Pilar
Hicheri, Yosr
Berger, Mathilde Hunault
Saillard, Colombe
Leguay, Thibaut
Loiseau, Clemence
Bene, Marie-Christine
Chevallier, Patrice
LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
[33] Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Tan, Xu
Chen, Guo
Ma, Yingying
Wang, Maihong
Wen, Qin
Liu, Hong
Zhang, Xi
Zhang, Cheng
BLOOD, 2024, 144 : 1449 - 1449
[34] Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study
Gong, Xiaoyuan
Fang, Qiuyun
Gu, Runxia
Qiu, Shaowei
Liu, Kaiqi
Lin, Dong
Zhou, Chunlin
Zhang, Guangji
Gong, Benfa
Liu, Yuntao
Wei, Shuning
Li, Yan
Li, Shouyun
Liu, Bingcheng
Hu, Yimin
Li, Junfan
Wang, Ying
Wei, Hui
Mi, Yingchang
Wang, Jianxiang
BLOOD, 2023, 142
[35] Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome
Hirabayashi, Shinsuke
Hasegawa, Daisuke
Yamamoto, Kaoru
Nishimura, Akira
Hosoya, Yosuke
Shuo, Takuya
Kiyokawa, Nobutaka
Miura, Masatomo
Takahashi, Naoto
Manabe, Atsushi
PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
[36] Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
Lim, Sung-Nam
Joo, Young-Don
Lee, Kyoo-Hyung
Kim, Dae-Young
Lee, Je-Hwan
Lee, Jung-Hee
Chi, Hyun-Sook
Yun, Sung-Cheol
Lee, Won Sik
Lee, Sang Min
Park, Seonyang
Kim, Inho
Sohn, Sang Kyun
Moon, Joon Ho
Ryoo, Hun-Mo
Bae, Sung Hwa
Hyun, Myung Soo
Kim, Min Kyoung
Kim, Hyeoung Joon
Yang, Deok-Hwan
Eom, Hyeon-Seok
Lee, Gyeong-Won
Jung, Chul Won
Won, Jong-Ho
Kim, Hawk
Lee, Jae-Hoon
Shin, Ho-Jin
Jang, Dae-Young
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (11) : 1013 - 1020
[37] Dasatinib-Combined Less Intensive Chemotherapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Down Syndrome
Hirabayashi, Shinsuke
Yamamoto, Shunsuke
Yamamoto, Kaoru
Yamamoto, Kazuki
Aiga, Saori
Daida, Atsuro
Ono, Rintaro
Ashiarai, Miho
Nishimura, Akira
Hosoya, Yosuke
Hasegawa, Daisuke
Manabe, Atsushi
PEDIATRIC BLOOD & CANCER, 2018, 65 : S97 - S97
[38] Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Ravandi, Farhad
O'Brien, Susan M.
Cortes, Jorge E.
Thomas, Deborah M.
Garris, Rebecca
Faderl, Stefan
Burger, Jan A.
Rytting, Michael E.
Ferrajoli, Alessandra
Wierda, William G.
Verstovsek, Srdan
Champlin, Richard
Kebriaei, Partow
McCue, Deborah A.
Huang, Xuelin
Jabbour, Elias
Garcia-Manero, Guillermo
Estrov, Zeev
Kantarjian, Hagop M.
CANCER, 2015, 121 (23) : 4158 - 4164
[39] Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
Yoon, J. -H.
Yhim, H. -Y.
Kwak, J. -Y.
Ahn, J. -S.
Yang, D. -H.
Lee, J. -J.
Kim, S. -J.
Kim, J. -S.
Park, S. J.
Choi, C. W.
Eom, H. -S.
Park, S. -K.
Choi, S. -Y.
Kim, S. -H.
Kim, D. -W.
Lee, S.
ANNALS OF ONCOLOGY, 2016, 27 (06) : 1081 - 1088
[40] Dasatinib monotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia with pulmonary infection in induction remission A case report and review of the literature
Zhang, Cheng
Luo, Xiao-Qing
Zhang, Xi
MEDICINE, 2018, 97 (38)

← 1 2 3 4 5 →